Negara: Belanda
Bahasa: Inggris
Sumber: HMA (Heads of Medicines Agencies)
cefquinome sulfate 75 mg/ml
Intervet
QJ01DE90
Suspension for injection
Cefquinome
Cattle
2011-03-11
Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT COBACTAN LA 7.5% w/v suspension for injection for cattle 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: Active substance: Cefquinome (as sulfate) 75 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Suspension for injection White to off-white resuspendable suspension 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of bovine respiratory disease (BRD) associated with _Mannheimia haemolytica, _ _Pasteurella multocida and Histophilus somni_ sensitive to cefquinome._ _ 4.3 CONTRAINDICATIONS Do not use in animals which are known to be hypersensitive to cephalosporin antibiotics and other β-lactam antibiotics. Do not use in poultry (including eggs) due to risk of spread of antimicrobial resistance to humans. 4.4 SPECIAL WARNINGS None. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Cobactan 7.5% selects for resistant strains such as bacteria carrying extended spectrum betalactamases (ESBL) which may constitute a risk to human health if these strains disseminate to humans e.g. via food. For this reason, Cobactan 7.5% should be reserved for the treatment of clinica l conditions which have responded poorly, or are expected to respond poorly (refers to very acute cases when treatment must be initiated without bacteriological diagnosis), to first line treatment. Official, national and regional antimicrobial policies should be taken into account when the product is used. Increased use, including use of the product deviating from the instructi Baca dokumen lengkapnya